Related Experiment Video
Updated: Jun 1, 2026

04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Premature ejaculation in patients with ankylosing spondylitis
F Tarhan1, H Tarhan, U Karaoğullarından
1Department of Rheumatology, Atatürk Training and Research Hospital, Izmir, Turkey.
International Journal of Andrology
|June 10, 2011
Summary
Premature ejaculation (PE) affects ankylosing spondylitis (AS) patients similarly to the general population. This study found no significant difference in PE prevalence between AS patients and healthy controls.
Area of Science:
- Urology
- Rheumatology
- Sexual Health
Background:
- Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine.
- Premature ejaculation (PE) is a common sexual dysfunction with various classifications.
- The relationship between AS and PE has not been previously investigated.
Purpose of the Study:
- To evaluate the prevalence and characteristics of premature ejaculation (PE) in male patients with ankylosing spondylitis (AS).
- To compare PE rates and intravaginal ejaculatory latency times (IELT) between AS patients and healthy controls.
Main Methods:
- A case-control study included 50 male AS patients and 50 healthy controls (NHC).
- Data collected included patient demographics, AS disease characteristics (duration, BASFI), and medication use.
- PE was diagnosed using medical and sexual history, classifying patients into lifelong, natural variable, acquired PE, or premature ejaculatory dysfunction, supplemented by self-estimated IELT.
Main Results:
- The prevalence of PE was 32% in AS patients and 30% in NHC, with no significant difference (p = 0.331).
- Average estimated IELT differed significantly between PE (10,009 ± 51.9 sec) and non-PE groups (145.26 ± 43.01 sec) (p = 0.000).
- Lifelong PE patients had lower mean IELT, while premature-like ejaculatory dysfunction patients had the highest IELT (p = 0.000).
Conclusions:
- Premature ejaculation (PE) occurs in men with ankylosing spondylitis (AS) at a prevalence comparable to the general population.
- No significant difference in PE prevalence or syndromes was observed between AS patients and healthy controls.
- Further multi-centered studies with larger cohorts are needed to confirm these findings.
Related Concept Videos
Male Sexual Response: Erection & Ejaculation
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

